Real-time enrollment status for this small cell lung cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT04471727 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Small Cell Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 232 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) |
| Last Updated on CT.gov | February 24, 2026 (6 days ago) |
As of March 2, 2026: Clinical trial NCT04471727 is currently active_not_recruiting participants. This clinical trial study for small cell lung cancer is not currently accepting new participants at 11 locations across the United States. The study is sponsored by Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA). This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04471727 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04471727 was last updated 6 days ago (February 24, 2026). HelloStudys verifies this status automatically.